BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17640229)

  • 1. Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions.
    Wiltz KL; Qureshi H; Patterson JW; Mayes DC; Wick MR
    J Cutan Pathol; 2007 Aug; 34(8):601-5. PubMed ID: 17640229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin.
    Beltraminelli H; Shabrawi-Caelen LE; Kerl H; Cerroni L
    Am J Dermatopathol; 2009 May; 31(3):305-8. PubMed ID: 19384076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical comparison between MiTF and MART-1 with Azure blue counterstaining in the setting of solar lentigo and melanoma in situ.
    Hillesheim PB; Slone S; Kelley D; Malone J; Bahrami S
    J Cutan Pathol; 2011 Jul; 38(7):565-9. PubMed ID: 21362015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical analysis of pseudomelanocytic nests mimicking melanoma in situ: report of 2 cases.
    Nicholson KM; Gerami P
    Am J Dermatopathol; 2010 Aug; 32(6):633-7. PubMed ID: 20559116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A.
    Helm K; Findeis-Hosey J
    J Cutan Pathol; 2008 Oct; 35(10):931-4. PubMed ID: 18494818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.
    Kligora CJ; Fair KP; Clem MS; Patterson JW
    Mod Pathol; 1999 Dec; 12(12):1143-7. PubMed ID: 10619267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol.
    Cherpelis BS; Moore R; Ladd S; Chen R; Glass LF
    Dermatol Surg; 2009 Feb; 35(2):207-13. PubMed ID: 19215257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation?
    Silva CY; Goldberg LJ; Mahalingam M; Bhawan J; Wolpowitz D
    J Cutan Pathol; 2011 Oct; 38(10):797-800. PubMed ID: 21812802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neoplastic cells in the lymphocytic infiltrate associated with thin melanomas.
    Salvio AG; Ribeiro DA; Marques ME
    Histopathology; 2007 Jun; 50(7):942-4. PubMed ID: 17543085
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2007 Dec; 29(6):566-7. PubMed ID: 18032954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical junctional melanocytic proliferations in benign lichenoid keratosis.
    Dalton SR; Fillman EP; Altman CE; Gardner TL; Davis TL; Bastian BC; Libow LF; Elston DM
    Hum Pathol; 2003 Jul; 34(7):706-9. PubMed ID: 12874767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MART-1 is a reliable melanocytic marker in lichen planus-like keratosis: a study on 70 cases.
    Gavino AC; Woods MT; Andea AA
    Am J Dermatopathol; 2011 Oct; 33(7):675-80. PubMed ID: 21885940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use and application of special techniques in assessing melanocytic tumours.
    Busam KJ
    Pathology; 2004 Oct; 36(5):462-9. PubMed ID: 15370117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain.
    Hendi A; Brodland DG; Zitelli JA
    Arch Dermatol; 2006 Jul; 142(7):871-6. PubMed ID: 16847203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melan-A/MART-1 positive "pseudonests" in lichenoid inflammatory lesions: an uncommon phenomenon.
    Demartini CS; Dalton MS; Ferringer T; Elston DM
    Am J Dermatopathol; 2005 Aug; 27(4):370-1. PubMed ID: 16121069
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.